Fast Company recognizes Obsidio among 2022 honorees in Health Category of World Changing Ideas

Obsidio recognized as winner of 2021 MedTech Innovation of the Year

PM360 Magazine selects Obsidio as one of the most innovative startups of the year

Obsidio, Inc. Expands Clinical Advisory Board With Two New Members

Obsidio, Inc. Awarded Prestigious Fast Track Small Business Innovation Research Grant by National Heart, Lung, and Blood Institute

Mayo Clinic researchers develop a tissue-derived bioactive gel to stop bleeding, aid in vascular healing

Preclinical studies at Mayo Clinic demonstrate new ways to stop bleeding

Obsidio, Inc. Closes $3 Million Round, Receives Grant from The National Science Foundation and Welcomes New Board Member

Obsidio, Inc. is selected as one of the five 2020 BIO Startup Stadium Winner!